Sales Lead Management Association Radio header image 1

Sales Lead Management Association Radio

15
Oct 2018

4 Cultural Values A Company Needs to Compete – Kevin Jones with Laura Patterson 22 Min. Podcast

00:0000:00

20180823-tweet-rsg-patterson-jones.jpg

Host, Laura Patterson interviews Kevin Jones, Founder and Former CEO Anovia for her monthly program: Ready, Set, Grow! 

Ready, Set, Grow! is to provide a venue for CXOs to share their insights on what it takes to successfully achieve organic growth, lessons learned, the role they believe Marketing needs to play in growth and how they measure Marketing’s contribution beyond this “quarters” revenue. 

About our guest, Kevin Jones:

Kevin Jones is all about driving growth through innovation, strategic partnerships, a results-oriented culture and keen risk management practices.  He founded Anovia Payments in 2013 and in its first four years the company had over 12,500 business customers. While at Anovia, President of SignaPay, other Executive roles (Chase Paymentech, First American Payment Systems), Kevin believes in building nimble, flexible organizations that succeed as a result of developing long, mutually profitable relationships. Later this year Kevin will be starting a new company, backed by a major private equity company and $100mm investable capital. Kevin, will be bringing his 20-year expertise in the payments industry to this new company that focuses on software integration to create added simplicity for merchants.

15
Oct 2018

Beck Taylor, COO, SensorRX on Ready, Set, Grow! with host, Laura Patterson

00:0000:00

20181018-tweet-rsg-taylor.jpg

This week, host, Laura Patterson interviews Beck Taylor, COO, SensorRX for her monthly program: Ready, Set, Grow! 

Ready, Set, Grow! is to provide a venue for CXOs to share their insights on what it takes to successfully achieve organic growth, lessons learned, the role they believe Marketing needs to play in growth and how they measure Marketing’s contribution beyond this “quarters” revenue. 

About our guest, Becky Taylor

Rebecca (Becky) Taylor is a senior level executive with solid background in visualizing and guiding new ventures including building committed teams and raising funds. Deep commitment to the power of personal and organizational networking. Experience in organizations ranging in size from very small start-up companies to multinationals and senior advisory roles at the U.S. Department of State. Skilled at analysis and distilling complex facts down to small set of relevant parameters. Other expertise includes technology licensing, venture capital investing, sales negotiations, identifying market opportunities. Multiple patent holder. Advisor to startups on funding strategies, technology planning, and negotiations. Prefer presenting to diverse audiences, large and small. Lifelong commitment of raising money and awareness for important community needs. One of the first EIRs at UT in 2009, graduated LBJ School as a non-traditional student in 2010.

Ms. Taylor’s most recent role involved leading a healthcare technology startup as Chief Operating Officer, through first revenue, funding round close and executive team expansion. At SensorRX, she was responsible for a broad range of actions pertaining to business operations and strategy. SensorRX is a chronic disease management technology provider initially focused on migraine headache management. Previously, Ms. Taylor held roles as Technology Innovation Advisor at Royal Dutch Shell, where she looked externally to find new technologies that improve operations in the global Wells, Deepwater, Water technology development groups at Shell, and as a Venture Principal with Shell Technology Ventures (STV), the corporate venture capital arm of Shell. Prior to joining STV, Ms. Taylor served as IEEE Diplomacy Fellow and Senior Advisor at the U.S. State Department, where she connected various bureaus and offices with the U.S. startup and university commercialization communities.

About SensorRX

SensorRX is a chronic disease management technology provider. It partners with large healthcare systems to improve treatment effectiveness and reduce the costs associated with a variety of chronic disease pathologies. The first chronic disease chosen to address, severe headache/migraine, counts 40 million US citizens amongst its sufferers. The company has reached the next stage in its growth and has relocated to Charlotte, NC. Becky served at the COO since 2016 and is now a shareholder, investor and as-needed advisor.